Effect of endothelin receptor antagonist on parathyroid gland growth, pth values and cell proliferation in azotemic rats

Autor: Ximena Jara, Andrea von Höveling, Arnold J. Felsenfeld, Sergio Mezzano, Aquiles Jara, M. Eugenia Burgos, Andrés Valdivieso
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Zdroj: NEPHROLOGY DIALYSIS TRANSPLANTATION
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Popis: Background. A variety of stimuli are involved in the pathogenesis of parathyroid gland hyperplasia in renal failure. Recently, it was shown that blocking the signal from the endothelin-1 (ET-1) receptor (ET A R/ET B R) by a non-selective receptor antagonist, bosentan, reduced parathyroid cell proliferation, parathyroid gland hyperplasia and parathyroid hormone (PTH) levels in normal rats on a calcium deficient diet. Our goal was to determine whether in 5/6 nephrectomized (NPX) rats with developing or established hyperparathyroidism, the endothelin receptor blocker, bosentan, reduced the increase in parathyroid cell proliferation, parathyroid gland hyperplasia and PTH values. Methods. High (HPD, 1.2%) or normal phosphorus diets (PD) (NPD, 0.6%) were given to 5/6 NPX rats for 15 days (NPX 15 ). In each dietary group, one-half the rats were given bosentan (B) i.p. 100mg/ kg/day. The four groups of rats were: (1) NPX 15 -1.2% P; (2) NPX 15 -1.2% P+B; (3) NPX 15 -0.6% P; and (4) NPX 15 -0.6% P+B. In a second study in which hyperparathyroidism was already established in 5/6 NPX rats fed a HPD for 15 days, rats were divided into two groups in which one group was maintained on a HPD and the other group was changed to very low PD (VLPD
Databáze: OpenAIRE